Evidence map›Paper›PMID 34294755›Full record

ArticleScientific reports2021

Context-dependent effects of whole-genome duplication during mammary tumor recurrence.

Rachel Newcomb, Emily Dean, Brock J McKinney, James V Alvarez

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Manipulation of the cell cycle by HIV-1.Biochemical Society transactions · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Double-checking chromosome segregation.The Journal of cell biology · 2023
    Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rachel NewcombDepartment of Pharmacology and Cancer Biology, Duke University, Durham, NC, 27710, USA.
Emily DeanDepartment of Pharmacology and Cancer Biology, Duke University, Durham, NC, 27710, USA.
Brock J McKinneyDepartment of Pharmacology and Cancer Biology, Duke University, Durham, NC, 27710, USA.
James V AlvarezDepartment of Pharmacology and Cancer Biology, Duke University, Durham, NC, 27710, USA. james.alvarez@duke.edu.
Duke University · US

Funding

Genetics and Genomics Training GrantT32GM136627 · NIGMS · DUKE UNIVERSITY · PI ALLISON E ASHLEY-KOCH · 2020 to 2026
$3.1M
Par-4 Regulation and Function in Breast Cancer Dormancy and RecurrenceR01CA208042 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ALVAREZ, JAMES V · 2016 to 2020
$2.1M
NCI NIH HHS R01 CA208042NIGMS NIH HHS T32 GM136627NIH HHS R01CA208042
6 · The paper itself

Abstract

Whole-genome duplication (WGD) generates polyploid cells possessing more than two copies of the genome and is among the most common genetic abnormalities in cancer. The frequency of WGD increases in advanced and metastatic tumors, and WGD is associated with poor prognosis in diverse tumor types, suggesting a functional role for polyploidy in tumor progression. Experimental evidence suggests that polyploidy has both tumor-promoting and suppressing effects, but how polyploidy regulates tumor progression remains unclear. Using a genetically engineered mouse model of Her2-driven breast cancer, we explored the prevalence and consequences of whole-genome duplication during tumor growth and recurrence. While primary tumors in this model are invariably diploid, nearly 40% of recurrent tumors undergo WGD. WGD in recurrent tumors was associated with increased chromosomal instability, decreased proliferation and increased survival in stress conditions. The effects of WGD on tumor growth were dependent on tumor stage. Surprisingly, in recurrent tumor cells WGD slowed tumor formation, growth rate and opposed the process of recurrence, while WGD promoted the growth of primary tumors. These findings highlight the importance of identifying conditions that promote the growth of polyploid tumors, including the cooperating genetic mutations that allow cells to overcome the barriers to WGD tumor cell growth and proliferation.

Indexed as

Gene DuplicationAnimalsCell Line, TumorCell ProliferationChromosomal InstabilityErb-b2 Receptor Tyrosine KinasesEvolution, MolecularFemaleHumansIn Situ Hybridization, FluorescenceKaryotypingMammary Neoplasms, ExperimentalMiceMice, TransgenicPolyploidyERBB2 protein, humanErb-b2 Receptor Tyrosine Kinases

Identifiers

PMID34294755
PMCPMC8298634
OpenAlexW3183592168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.